Keywords:
Acute cardio-oncology; anthracyclines; cardio-oncology; checkpoint inhibitors; frameworks for cardio-oncology; models of care; molecular inhibitors; pediatric oncology; radiation therapy
Abstract:
Cardio-oncology is a new multidisciplinary area of expertise that seeks to pre-emptively and proactively address cardiac complications that emerge during and following cancer therapy. Modern therapies including molecular targeted therapy and immunotherapy have broadened the agents that can cause cardiac sequelae, often with complications arising within days to weeks of therapy.